Lupin Announces Approval from U.S. FDA for Pitolisant Tablets

MUMBAI, India and NAPLES, Fla., Aug. 17, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received the final approval from the United States Food and Drug Administration (U....